ATC code none PubChem CID 133090 ChemSpider 117450 Molar mass 382.454 g/mol | CAS Number 174636-32-9 IUPHAR/BPS 2124 UNII CZ3T9T146K | |
 | ||
Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome however its use as a potential antipsychotic drug for the treatment of schizophrenia has been discontinued.
References
Talnetant Wikipedia(Text) CC BY-SA